Skip to main content

Table 2 Baseline demographics

From: Randomized, double-blind, crossover study comparing DFN-11 injection (3 mg subcutaneous sumatriptan) with 6 mg subcutaneous sumatriptan for the treatment of rapidly-escalating attacks of episodic migraine

Variable

Value

Gender n (%)

 Male

4 (20)

 Female

16 (80)

Age (years)a

39.8 (10.4)

 Range

19–61

Race n (%)

 Caucasian

19 (95)

 Hispanic

1 (5)

Headache Characteristicsa

 Migraine Days/Month

5.0 (3.7)

 Headache Days/Month

6.8 (1.7)

  1. aValues are mean (SD)
Back to article page

The Journal of Headache and Pain

ISSN: 1129-2377

Contact us